Risk factors for recurrent vulvovaginal candidiasis [2] (multiple letters)

American Journal of Obstetrics and Gynecology

Volumn 192, Issue 3, 2005, Pages 981-982

  Farage, Miranda A ^a   Stadler, Angela ^a   Patel, Divya A ^b   Foxman, Betsy ^b   Nyirjesy, Paul ^b  

^a PROCTER AND GAMBLE COMPANY   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

ANTIBIOTIC THERAPY; CANDIDA; COMORBIDITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; HUMAN; HYGIENE; INFECTION RISK; LETTER; MAINTENANCE THERAPY; MENSTRUATION; PREVALENCE; PRIORITY JOURNAL; PROTECTION; RECURRENCE RISK; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; SYMPTOMATOLOGY; UROGENITAL TRACT INFECTION; VAGINA CANDIDIASIS;

EID: 14644420886     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2004.08.020     Document Type: Letter

References (4)

1. D.A. Patel B. Gillespie J.D. Sobel Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy: results of a prospective cohort study Am J Obstet Gynecol 190 2004 644 653
2. B. Foxman The epidemiology of vulvovaginal candidiasis: risk factors Am J Public Health 80 1990 329 331
3. M.A. Farage Labial and vaginal microbiology: effects of extended panty liner use Infect Dis Obstet Gynecol 5 1997 252 258
4. A.O. Berg F.E. Heidrich S.D. Fihn Establishing the cause of genitourinary symptoms in women in a family practice: comparison of clinical examination and comprehensive microbiology JAMA 251 1984 620 625